Bringing the fundamentals into focus…
Back to Sanara MedTech Inc.
How Sanara MedTech Inc. stacks up
SMTI · against 347 other Healthcare companies of similar size
Valuation
81/ 100
Near the top of its peers.
Ranked #62 of 348 · scores higher than 82% of peers
Bars: peers in each 10-point band of the valuation score22 peers with a valuation score of 80–89, including SMTI · Click a bar to see the companies
Why valuation scores 81?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Earnings yield is close to the peer norm. Earnings yield: 14.6% vs peer median 1.5%
- EBITDA yield is close to the peer norm. EBITDA yield: 3.5% vs peer median 4.0%
- Free cash flow yield is close to the peer norm. Free cash flow yield: 1.5% vs peer median 0.0%
Metric by metric
Position: dot = SMTI, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | SMTI | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 332 reported | -0.1% | -0.4% | 52% | 30% | |
| EBITDA yieldHigher is better · 354 reported | 3.9% | 1.8% | 57% | 50% | |
| Free cash flow yieldHigher is better · 179 reported | 1.5% | -9.2% | 76% | 20% | |
| Book yieldHigher is better · 340 reported | 2.7% | 51.5% | 7% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around SMTIScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score